HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: ps.051879606v1 15/5/1133    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gibson, T. J. Articles by Murphy, R. M. Search for Related Content PubMed PubMed Citation Articles by Gibson, T. J. Articles by Murphy, R. M. Social Bookmarking                   What's this?

Inhibition of insulin fibrillogenesis with targeted peptides

Department of Chemical and Biological Engineering, University of Wisconsin, Madison, Madison, Wisconsin 53706, USA

(RECEIVED September 29, 2005; FINAL REVISION February 3, 2006; ACCEPTED February 9, 2006)

Under conditions of acidic pH and elevated temperature, insulin partially unfolds and aggregates into highly structured amyloid fibrils. Aggregation of insulin leads to loss of activity and can trigger an unwanted immune response. Compounds that prevent protein aggregation have been used to stabilize insulin; these compounds generally suppress aggregation only at relatively high inhibitor concentrations. For example, effective inhibition of aggregation of 0.5 mM insulin required arginine concentrations of 100 mM. Here, we investigate a targeted approach toward inhibiting insulin aggregation. VEALYL, corresponding to residues B12–17 of full-length insulin, was identified as a short peptide that interacts with full-length insulin. A hybrid peptide was synthesized that contained this binding domain and hexameric arginine; this peptide significantly reduced the rate of insulin aggregation at near-equimolar concentrations. An effective binding domain and N-terminal placement of the arginine hexamer were necessary for inhibitory activity. The data were analyzed using a simple two-step model of aggregation kinetics. These results are useful not only in identifying an insulin aggregation inhibitor but also in extending a targeted protein strategy for modifying aggregation of amyloidogenic proteins.

Keywords: aggregation; amyloid; surface tension; insulin

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				W. F. Weiss IV, T. K. Hodgdon, E. W. Kaler, A. M. Lenhoff, and C. J. Roberts Nonnative Protein Polymers: Structure, Morphology, and Relation to Nucleation and Growth Biophys. J., December 15, 2007; 93(12): 4392 - 4403. [Abstract] [Full Text] [PDF]